O'Dell Group’s Eli Lilly LLY Stock Holding History

O'Dell Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-668	Closed	-$516K	–	68
2024 Q4	$516K	Sell	668 -362	-35%	-$300K	0.12%	50
2024 Q3	$912K	Buy	1,030 +79	+8%	+$71K	0.2%	36
2024 Q2	$740K	Hold	951	–	–	0.18%	42
2024 Q1	$740K	Buy	951 +67	+8%	+$47.7K	0.18%	42
2023 Q4	$516K	Buy	884 +17	+2%	+$9.92K	0.13%	42
2023 Q3	$466K	Buy	867 +3	+0.3%	+$1.55K	0.14%	43
2023 Q2	$405K	Buy	+864	New	+$362K	0.12%	49
2022 Q4	–	Sell	-424	Closed	-$137K	–	259
2022 Q3	$137K	Hold	424	–	–	0.05%	80
2022 Q2	$137K	Hold	424	–	–	0.05%	82
2022 Q1	$121K	Hold	424	–	–	0.04%	103
2021 Q4	$117K	Hold	424	–	–	0.03%	103
2021 Q3	$98K	Buy	+424	New	+$105K	0.03%	111

Other funds holding LLY

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

O'Dell Group's LLY Position: Q1 2025 in Review

O'Dell Group sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 668 shares — an estimated $516K sold.

O'Dell Group first reported a position in LLY in Q3 2021 and held it in 12 quarters. The position peaked at $912K in Q3 2024. 3,927 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

O'Dell Group reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
O'Dell Group sold 668 Eli Lilly shares in Q1 2025, an estimated $516K.
O'Dell Group first reported a position in Eli Lilly in Q3 2021 and held it in 12 quarters.
O'Dell Group's Eli Lilly position peaked at $912K in Q3 2024.
3,927 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on O'Dell Group's 13F filing for Q1 2025, filed 21 Apr 2025.